KING & SPALDING LLP

Lobbying for EGENESIS INC. · Gene editing platform for the development of transplantable organs.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · $60,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

Educate lawmakers on xenotransplantation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem